Background: It is postulated that clinical and radiographic peri-implant parameters are worse and
| I NTR OD U CTI ON
It is well-instituted that habitual tobacco smoking is one of the classical risk-factors of bone loss around natural teeth and dental implants. 1, 2 Research indicates that habitual smoking elevate the production and amounts of advanced glycation endproducts (AGEs) in oral structures including gingival tissues and periodontal fibroblasts. of cigarette smokers (CS). 6, 7 This increase in proinflammatory cytokines thereby result in cellular dysfunction and an altered cellular phenotype. 8 Furthermore, it has also been reported that AGEs mediate inflammation of human periodontal tissues via the endoplasmic reticulum stress-induced nuclear factor-kappa-B pathway. 9 These are possible mechanisms that enhance periodontal soft tissue inflammation and alveolar bone loss around natural teeth and dental implants among tobacco smokers.
It is postulated that the same mechanisms may be associated with soft tissue inflammation and crestal bone loss (CBL) around dental implants in smokeless-tobacco users (STU). A recent cross-sectional study by Akram and colleagues, 10 showed that clinical and radiographic periodontal parameters are worse among habitual STU. This was further tested in a clinico-laboratory study by Daood and colleagues, 11 that reported enhanced collagen breakdown around teeth of STU. and MMP-9 levels among CS, STU, and NTU.
| M AT ER I AL S A N D M E TH ODS

| Ethical guidelines
The present study was performed following guidelines recognized by the Declaration of Helsinki as revised in 2013 for experimentation involving human patients. The study protocol was reviewed and approved by the research ethics review committee of Jinnah Hospital, Karachi, Pakistan (OR-763-2016). All participants were requested to read and sign a consent form that explained the objectives and methods of the present study. All individuals had the right to retire from the study at any stage without penalty.
| Study groups
Between June 2016 and March 2017, a total of 131 individuals were enrolled from private dental referral clinic (Dr Z. Akram, Pakistan). All study participants had noncontributory medical condition and were either habitual CS (Group-1), STU (Group-2), or had never used tobacco in any form NTU (Group-3). 
| Eligibility criteria
| Study questionnaire
All participants completed a baseline structured questionnaire that 
| Clinical peri-implant assessment
All clinical examinations were carried out by a trained examiner (ZA), who was blinded to the study groups. The kappa value for intraassessor reliability assessing peri-implant probing depth (PD) was 0.94 which was considered a good agreement. Peri-implant status was based on recording peri-implant plaque index (PI), bleeding on probing (BOP), and PD 4 mm with references to the Consensus report of the Seventh European Workshop on Periodontology-2011. 13 All recordings were assessed at six sites per implant (mesiobuccal, mid-buccal, distobuccal, distolingual/palatal, mid-lingual/palatal, and mesiolingual/ palatal) and reported as mean percentages per individual. Probing depth was measured to the closest millimeter by the help of a manual periodontal probe (UNC-15 Hu-Friedy, Chicago, Illinois).
| Crestal bone loss
All radiographic examinations were carried out by a trained assessor (FV) who was blinded to the study groups (kappa 5 0.89). Digital periapical radiographs were taken and assessed on a standardized computer display (Samsung SyncMaster digital TV monitor, Korea) using a software program (Image Tool 3.0 Program, San Antonio, Texas).
14 Crestal bone loss was defined as the total distance from the topmost supracrestal part of the dental implant to the crest of the alveolar bone. 15 
| Collection of peri-implant sulcular fluid
After carefully removing the supragingival oral biofilm, the peri-implant sites were isolated with sterile cotton rolls and dried gently with an air samples from the same site were pooled and eluted in 1 ml phosphate buffered saline for 1 hour before freezing at 2808C.
| Measurement of interleukin-1b and matrix metalloproteinase-9 in peri-implant sulcular fluid
Analyses of biomarkers were carried out by a trained technician, who was blinded to the study groups. Centrifugation of all PISF samples were carried out at 5000g for 15 minutes at 48C. Levels of IL-1b and MMP-9 were quantified using enzymatic immunosorbent assay according to the manufacturer's recommendations (Quantikine, R&D Systems, Minneapolis, Minnesota). In summary, 100 ll of detection antibody was dispensed in to the wells, except blank, mixed gently, and incubated overnight at room temperature. Plates were washed thrice and standards and PISF were dispensed, in duplicate, into the wells.
Following incubation, the plates were washed again and incubated with 100 ml of conjugate for 1 hour at room temperature. Plates were washed again thrice and 100 ml of substrate was dispensed and incubated in the dark for 15 minutes at room temperature. The reaction was terminated by adding 50 ml stop solution, and absorbance was determined in an automated microplate spectrophotometer (Microplate Reader/Model 3550, Bio Rad). The levels of IL-1b and MMP-9 were determined as picograms per millilitres (pg/ml) and nanograms per millilitres (ng/ml), respectively. Results were calculated using the standard curves created in each assay.
| Statistical analyses
Statistical analyses were carried out using a statistical software (SPSS v. 
20, IBM, Chicago, Illinois
| Clinical and radiographic peri-implant parameters
The mean findings of peri-implant PI (P < .05) and PD 4 mm (P < .05)
were significantly worse in group-1 and group-2 patients as compared to group-3 individuals. Peri-implant BOP (P < .01) was significantly higher in group-2 and group-3 as compared to individuals in group-1.
Peri-implant BOP was significantly higher in group-2 patients as compared to group-3 patients (P < .05). Peri-implant PI and PD 4 mm were comparable among individuals in group-1 and group-2 ( Table 2 ).
Crestal bone loss was significantly higher in group-1 and group-2 patients as compared to group-3 individuals (P < .05). Similarly, there was no significant difference in CBL between group-1 and group-2 patients (P > .05) ( Table 2) . 
| Levels of IL-1b and MMP-9 in PISF
The PISF volume (P < .05) collected and levels of IL-1b (P < .01) and MMP-9 (P < .01) were statistically significantly elevated in individuals in groups 1 and 2 compared with group-3. There was no statistically significant difference in the PISF levels of IL-1b and MMP-9 among groups 1 and 2 (Table 3) .
| Stratification of peri-implant parameters for cigarette smokers and smokeless tobacco users according to duration of habit
Peri-implant BOP was significantly different between same subgroups of CS and STU when data stratified for 12 years. There was no statistically significant influence of the duration of cigarette smoking or smokeless tobacco usage on the severity of peri-implant PI, BOP, PD 4 mm, and crestal bone loss among CS and STU, respectively (Table 4) .
| DI SCUS SION
It is well-documented that clinical periodontal parameters among CS and STU have increased percentage of deep probing depths, a higher clinical attachment loss, and increased alveolar bone loss compared with NTU 16, 17 ; however, to our information from the literature, the present study is the first study to compare clinical and radiographic parameters around dental implants and proinflammatory cytokine levels among CS (Group-1), STU (Group-2), and NTU (Group-3). The purpose of the present study is supported on the hypothesis that periimplant clinical and radiographic inflammatory parameters are worse in CS and STU compared with nontobacco users. The outcomes of the present investigation are in accordance with this hypothesis.
One explanation for this outcome is that smoke from cigarettes expose its consumers to the toxic substances, such as carbon monoxide, nicotine, and tar. 18, 19 Moreover, research indicates that nicotine in tobacco upregulates the secretion of proinflammatory cytokines (such as IL-1b and MMP-9), which play a key role in alveolar bone deterioration around natural teeth. 20, 21 Increased expression of these proinflammatory cytokines have also been detected in the PISF of patients with peri-implantitis. 22, 23 Furthermore, findings from a recent meta-analysis showed that tobacco smoking impairs new bone formation around dental implants and jeopardizes bone-to-implant contact. 24 Nicotine in tobacco smoke has been reported to reduce the cellular healing response and increase the levels of the oral bacterial count (a potential risk factor that may lead to peri-implantitis) in CS. 25 The findings of the present study corroborates with the study by Barão and colleagues 25 since the number of peri-implant sites with plaque accumulation were statistically significantly higher among individuals in CS and STU compared with NTU. It is also noteworthy that percentage of peri-implant sites with positive BOP were significantly higher in STU and NTU compared with participants in CS. It is known that clinical assessment of BOP is a traditional marker for periodontal and periimplant soft tissue inflammation. 26 However, cigarette smokers may remain unaware of the continuous oral soft tissue inflammatory changes as they present less bleeding signs in gingival tissues compared with nonsmoker. 27 It is suggested that nicotine exerts vasoconstriction on gingival blood vessels, which in turn reduces gingival bleeding in smokers compared with individuals who do not smoke. 27, 28 The present results clearly indicates why individuals in CS exhibited fewer percentage of BOP as compared to NTU and STU, it is their oral hygiene that generally contributes in excessive BOP. 10 The present result showed the levels of detrimental proinflammatory biomarkers (IL-1b and MMP-9) were statistically significantly higher among individuals in group-1 and group-2 compared with group-3. One explanation in this regard is that habitual smoking increases the formation and accumulation of AGEs in oral tissues including gingival and periodontal tissues. 29 Augmented interfaces between AGEs and their receptors (RAGEs) have been associated with the formation of ROS that induce a state of oxidative burst within gingival tissues, functional alterations of chemotaxis and phagocytosis of 
| CON CLU S I ON
Clinical and radiographic peri-implant parameters were compromised among CS and STU as compared to NTU. Increased expression of local proinflammatory cytokines may explain greater susceptibility of CS and STU to peri-implant breakdown. 
